Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules
Oncolytics Biotech® Inc. Logo (PRNewsfoto/Oncolytics Biotech® Inc.)
As previously announced, the Company was notified by Nasdaq on February 13, 2025, that the Company's common shares failed to maintain a minimum bid price of US$1.00 over the previous 30 consecutive business days as required by the Minimum Bid Price Requirement. According to the Compliance Notice, the Company regained compliance with the Minimum Bid Price Requirement because the closing bid price of the Company's common shares has been at or above $1.00 per share for 10 consecutive business days, from July 8, 2025, through July 21, 2025, and the matter is now closed.
About Oncolytics Biotech Inc.
Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 studies in metastatic breast cancer and Phase 1 and 2 studies in pancreatic cancer. It acts by inducing anti-cancer immune responses and promotes an inflamed tumor phenotype – turning "cold" tumors "hot" – through innate and adaptive immune responses to treat a variety of cancers.
Pelareorep has demonstrated synergies with multiple approved oncology treatments. Oncolytics is currently conducting and planning combination clinical trials with pelareorep in solid malignancies as it advances towards registrational studies in metastatic breast cancer and pancreatic cancer, both of which have received Fast Track designation from the FDA. For more about Oncolytics, please visit: www.oncolyticsbiotech.com or follow the company on social media on LinkedIn and on X @oncolytics.
Company Contact
Jon Patton
Director of IR & Communication
jpatton@oncolytics.ca
Investor Relations for Oncolytics
Mike Moyer
LifeSci Advisors
+1-617-308-4306
mmoyer@lifesciadvisors.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Amazon (AMZN) Price Target Raised to $271 — Here's What's Driving It
Inc. (NASDAQ:AMZN) is one of the . On July 28, UBS analyst Stephen Ju raised the price target on the stock to $271.00 (from $249.00) while maintaining a Buy rating. The price target increase reflects UBS's decision to roll back some of the decreases in estimates it had made three months ago when it was expecting increased demand destruction from tariffs. The firm has raised its Gross Merchandise Value (GMV) estimates for 2026 by an estimated 2%, along with a 2% increase in gross profit projections. Moreover, it has also raised its 2026 and 2027 advertising segment forecasts by an estimated 3% due to better-than-expected advertising performance. Meanwhile, AWS growth estimates were maintained at 16% for the second quarter of 2025. 25 best things to buy on Amazon under $20 (Photo credit: Pixabay) Based on the revisions, there is a 1% increase in 2026 revenue estimates and a 5% increase in EBIT (Earnings Before Interest and Taxes) projections. For the year 2027, the firm projects a 0.1% revenue increase and a 7% EBIT increase. The firm also raised its 2025 CapEx forecast to $112 billion from the previous $107 billion after the company disclosed its first-quarter 2025 capital expenditures. Inc. (NASDAQ:AMZN) is an American technology company offering e-commerce, cloud computing, and other services, including digital streaming and artificial intelligence solutions. While we acknowledge the potential of AMZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Business Wire
an hour ago
- Business Wire
Cintas Corporation Announces 15.4% Increase in Quarterly Cash Dividend
CINCINNATI--(BUSINESS WIRE)--Cintas Corporation (Nasdaq: CTAS) announced that the Company's Board of Directors approved a quarterly cash dividend of $0.45 per share of common stock payable on September 15, 2025, to shareholders of record at the close of business on August 15, 2025. This represents a 15.4% increase. Cintas has a strong record of returning capital to its shareholders and has consistently raised its dividend each year since Cintas' initial public offering 42 years ago in 1983. Any future dividend declarations, including the amount of any dividends, are at the discretion of the Board of Directors and dependent upon then-existing conditions, including the Company's operating results and financial condition, capital requirements, contractual restrictions, business prospects and other factors that the Board of Directors may deem relevant. Todd M. Schneider, Cintas' President, and Chief Executive Officer, stated, 'We achieved record revenue and profit in our fiscal 2025. We grew sales and profit again, which is now 54 out of the last 56 years. Due to our excellent financial results and strong financial position, we are increasing our quarterly dividend. The dividend, accompanied by our share buyback program, continues to demonstrate our commitment to increasing shareholder value.' Cintas Cintas Corporation helps more than one million businesses of all types and sizes get Ready™ to open their doors with confidence every day by providing products and services that help keep their customers' facilities and employees clean, safe and looking their best. With offerings including uniforms, mats, mops, towels, restroom supplies, workplace water services, first aid and safety products, eye-wash stations, safety training, fire extinguishers, sprinkler systems and alarm service, Cintas helps customers get Ready for the Workday®. Headquartered in Cincinnati, Cintas is a publicly held Fortune 500 company traded over the Nasdaq Global Select Market under the symbol CTAS and is a component of both the Standard & Poor's 500 Index and Nasdaq-100 Index.
Yahoo
an hour ago
- Yahoo
Amazon Q2 Preview: Can AWS and Ads Outrun Tariff Trouble?
Inc. (NASDAQ:AMZN) will report second-quarter earnings after the bell on Thursday, July 31. Consensus forecasts call for EPS of $1.33 and revenue of $162.18 billion, implying a 10% YoY top-line increase and continued margin expansion. The stock is up just 5% YTD, but has rallied 43% since the April low and now trades about 4% below its all-time high of $242.52, set on February 4. The key swing factor remains AWS. After posting 13% growth YoY last quarter, investors will be watching closely for signs of continued acceleration and any GenAI monetization progress. Retail margin improvement is another focal point. North America posted a 6.3% operating margin last quarter, and bulls are looking for more operating leverage as cost cuts and logistics efficiencies flow through. Amazons growing ad business, which reached $13.9 billion in Q1, is also expected to remain a pillar of high-margin growth. Watch for commentary on consumer demand, international performance, and guidance for Q3, particularly as macro tailwinds fade and regulatory scrutiny intensifies. Trade pressures could also return to the forefront. Amazon previously said it would increase pricing transparency by showing U.S. consumers tariff-related charges on product pages but walked that back after backlash from the Trump administration. With baseline tariffs around 15% on imports expected in August, commentary on whether Amazon will absorb those costs or pass them on to consumers will be closely watched. Higher duties could squeeze margins in key categories like electronics and apparel. Finally, although Prime Day falls in Q3, this July marks the first time Amazon has expanded Prime Day to four days. Any color on early results or consumer response could help frame the companys third-quarter guidance and gauge broader retail strength heading into the back half of the year. Valuation remains elevated at nearly 37x forward earnings, reflecting optimism around AWS momentum and retail margin expansion. But with shares near record levels, any disappointment on cloud growth, spending trends, or tariff commentary could test investor conviction. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
